Warby Parker Inc (WRBY) - Net Assets
Based on the latest financial reports, Warby Parker Inc (WRBY) has net assets worth $375.81 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($736.41 Million) and total liabilities ($360.60 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of Warby Parker Inc to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $375.81 Million |
| % of Total Assets | 51.03% |
| Annual Growth Rate | 30.8% |
| 5-Year Change | 28.58% |
| 10-Year Change | N/A |
| Growth Volatility | 118.08 |
Warby Parker Inc - Net Assets Trend (2019–2025)
This chart illustrates how Warby Parker Inc's net assets have evolved over time, based on quarterly financial data. See Warby Parker Inc (WRBY) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Warby Parker Inc (2019–2025)
The table below shows the annual net assets of Warby Parker Inc from 2019 to 2025. For live valuation and market cap data, see Warby Parker Inc (WRBY) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $367.73 Million | +8.13% |
| 2024-12-31 | $340.07 Million | +12.69% |
| 2023-12-31 | $301.79 Million | +5.28% |
| 2022-12-31 | $286.65 Million | +0.23% |
| 2021-12-31 | $286.00 Million | -7.27% |
| 2020-12-31 | $308.41 Million | +320.20% |
| 2019-12-31 | $73.40 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Warby Parker Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 41610900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $12.00K | 0.00% |
| Other Comprehensive Income | $-1.48 Million | -0.40% |
| Other Components | $1.05 Billion | 286.84% |
| Total Equity | $367.73 Million | 100.00% |
Warby Parker Inc Competitors by Market Cap
The table below lists competitors of Warby Parker Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Urban Edge Properties
NYSE:UE
|
$2.95 Billion |
|
Relay Therapeutics Inc
NASDAQ:RLAY
|
$2.95 Billion |
|
Chesapeake Utilities Corporation
NYSE:CPK
|
$2.95 Billion |
|
Kaiser Aluminum Corporation
NASDAQ:KALU
|
$2.95 Billion |
|
Beijing Toread Outdoor Product
SHE:300005
|
$2.94 Billion |
|
First BanCorp
F:OLWN
|
$2.94 Billion |
|
PNB Housing Finance Limited
NSE:PNBHOUSING
|
$2.94 Billion |
|
NMI Holdings Inc
NASDAQ:NMIH
|
$2.94 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Warby Parker Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 340,073,000 to 367,730,000, a change of 27,657,000 (8.1%).
- Net income of 1,641,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 457,000.
- Other factors increased equity by 25,559,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.64 Million | +0.45% |
| Other Comprehensive Income | $457.00K | +0.12% |
| Other Changes | $25.56 Million | +6.95% |
| Total Change | $- | 8.13% |
Book Value vs Market Value Analysis
This analysis compares Warby Parker Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.36x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 41.74x to 9.36x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $0.66 | $27.50 | x |
| 2020-12-31 | $2.77 | $27.50 | x |
| 2021-12-31 | $2.52 | $27.50 | x |
| 2022-12-31 | $2.49 | $27.50 | x |
| 2023-12-31 | $2.57 | $27.50 | x |
| 2024-12-31 | $2.82 | $27.50 | x |
| 2025-12-31 | $2.94 | $27.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Warby Parker Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.45%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.19%
- • Asset Turnover: 1.21x
- • Equity Multiplier: 1.96x
- Recent ROE (0.45%) is above the historical average (-30.28%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -78.39% | -15.53% | 2.11x | 2.40x | $-64.88 Million |
| 2020 | -18.13% | -14.20% | 0.89x | 1.44x | $-86.76 Million |
| 2021 | -50.44% | -26.68% | 1.23x | 1.54x | $-172.87 Million |
| 2022 | -38.51% | -18.46% | 1.05x | 1.98x | $-139.06 Million |
| 2023 | -20.94% | -9.44% | 1.15x | 1.92x | $-93.38 Million |
| 2024 | -6.00% | -2.64% | 1.14x | 1.99x | $-54.40 Million |
| 2025 | 0.45% | 0.19% | 1.21x | 1.96x | $-35.13 Million |
Industry Comparison
This section compares Warby Parker Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,119,701,400
- Average return on equity (ROE) among peers: -37.16%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Warby Parker Inc (WRBY) | $375.81 Million | -78.39% | 0.96x | $2.95 Billion |
| Akoya Biosciences Inc (AKYA) | $121.35 Million | -35.38% | 0.57x | $64.44 Million |
| Align Technology Inc (ALGN) | $85.74 Million | 10.23% | 0.52x | $12.09 Billion |
| AngioDynamics Inc (ANGO) | $545.02 Million | -0.62% | 0.42x | $447.90 Million |
| AptarGroup Inc (ATR) | $1.25 Billion | 9.94% | 0.56x | $7.66 Billion |
| AtriCure Inc (ATRC) | $186.69 Million | -14.58% | 0.46x | $1.38 Billion |
| Avinger Inc (AVGR) | $15.59 Million | -303.70% | 2.47x | $1.52 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $-253.00K | 0.00% | 0.00x | $924.75 Million |
| Avantor Inc (AVTR) | $2.46 Billion | 1.54% | 2.97x | $5.44 Billion |
| Azenta Inc (AZTA) | $632.04 Million | 2.25% | 0.20x | $1.07 Billion |
| Baxter International Inc (BAX) | $5.89 Billion | -41.27% | 3.80x | $9.94 Billion |
About Warby Parker Inc
Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses … Read more